Joy Schechtman, DO
Enriched profileRheumatologist; Founder/Head, Sun Valley Arthritis Center, Ltd. · Sun Valley Arthritis Center
Joy Schechtman is Rheumatologist; Founder/Head, Sun Valley Arthritis Center, Ltd. at Sun Valley Arthritis Center. ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Joy Schechtman, DO, is Rheumatologist at Sun Valley Arthritis Center, Ltd. (Peoria, AZ). The public record shows 24 publications with 2,437 citations (h-index 12), centered on Osteoarthritis. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 54 companies.
- Top research focus: Osteoarthritis
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 54 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Study of Flavocoxid (Limbrel) Versus Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee
Sponsor: Primus Pharmaceuticals
- Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study
Sponsor: Primus Pharmaceuticals
Industry payments
Updated 27 Aug 2026
54 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202563 payments$29,130openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202542 payments$15,820openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year202512 payments$15,395openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
82.7%TNF inhibitor45.8%Certolizumab pegol61%Golimumab32%Infliximab7%Humira(Cf)0%Part D + Part B<11 patientsInterleukin-6 Receptor Antagonist23.4%Tocilizumab100%Part B, office-administered≥38 patientsMusculoskeletal
15.3%Other drugs affecting bone structure and mineralization10.5%Romosozumab-aqqg100%Evenity (2 Syringes)0%Part D + Part B<11 patientsRANK Ligand Inhibitor4.8%Denosumab99%Prolia1%Part D + Part B≥407 patientsDermatology
1.6%Corticosteroid1.6%Triamcinolone acetonide54%Methylprednisolone acetate46%Part B, office-administered≥254 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor0%Acyclovir100%Part D≥20 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
acr23.eventscribe.net/ajaxcalls/presenterInfo.asp
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acr23.eventscribe.net ↗ - Other
mededhq.azosteo.org/speaker/joy-schechtman-874713
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mededhq.azosteo.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →joyschechtmando.healthpage.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →joyschechtmando.healthpage.org ↗
- Board Certified
Internal Medicine, American Osteopathic Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →honorhealth.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acr23.eventscribe.net ↗
- Principal Investigator on 200+ clinical studies (currently ~20 active)
including rheumatoid arthritis, psoriatic arthritis, polymyalgia rheumatica, vaccinations, and osteoporosis trials
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acr23.eventscribe.net ↗ - Member
American Arthritis and Rheumatology Association (AARA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sunvalleyarthritiscenter.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acr23.eventscribe.net ↗
Secondary affiliations
appointments beyond the home institution- Professor of Clinical Medicine
Midwestern University (Arizona College of Osteopathic Medicine), since 2014
2014provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acr23.eventscribe.net ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →honorhealth.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →abrazohealth.com ↗
Media & interviews
press, podcasts and appearances- Panel video "Trial-and-Error Approach to RA Treatment" with Nehad Soloman
MD and Robert Levine, MD, on Rheumatology Live / HCPLive network
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rheum-live.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University